NO20015605L - Substituerte polysykliske aryl- og heteroarylpyrazinoner som er anvendbare for selektiv inhibering av koagulasjonskaskaden - Google Patents
Substituerte polysykliske aryl- og heteroarylpyrazinoner som er anvendbare for selektiv inhibering av koagulasjonskaskadenInfo
- Publication number
- NO20015605L NO20015605L NO20015605A NO20015605A NO20015605L NO 20015605 L NO20015605 L NO 20015605L NO 20015605 A NO20015605 A NO 20015605A NO 20015605 A NO20015605 A NO 20015605A NO 20015605 L NO20015605 L NO 20015605L
- Authority
- NO
- Norway
- Prior art keywords
- heteroarylpyrazinones
- useful
- coagulation cascade
- selective inhibition
- polycyclic aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13495899P | 1999-05-19 | 1999-05-19 | |
| PCT/US2000/008225 WO2000069834A1 (en) | 1999-05-19 | 2000-05-18 | Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20015605D0 NO20015605D0 (no) | 2001-11-16 |
| NO20015605L true NO20015605L (no) | 2002-01-18 |
Family
ID=22465803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20015605A NO20015605L (no) | 1999-05-19 | 2001-11-16 | Substituerte polysykliske aryl- og heteroarylpyrazinoner som er anvendbare for selektiv inhibering av koagulasjonskaskaden |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1202975B1 (no) |
| JP (1) | JP2002544264A (no) |
| KR (1) | KR20010113971A (no) |
| CN (1) | CN1351595A (no) |
| AR (1) | AR029752A1 (no) |
| AT (1) | ATE292629T1 (no) |
| AU (1) | AU775229B2 (no) |
| BR (1) | BR0011295A (no) |
| CA (1) | CA2372617A1 (no) |
| CZ (1) | CZ20014115A3 (no) |
| DE (1) | DE60019296T2 (no) |
| EA (1) | EA005031B1 (no) |
| ES (1) | ES2240100T3 (no) |
| HU (1) | HUP0202191A3 (no) |
| IL (1) | IL146245A0 (no) |
| MX (1) | MXPA01011807A (no) |
| NO (1) | NO20015605L (no) |
| NZ (1) | NZ514876A (no) |
| PE (1) | PE20010290A1 (no) |
| PL (1) | PL352368A1 (no) |
| SK (1) | SK15872001A3 (no) |
| UY (1) | UY26155A1 (no) |
| WO (1) | WO2000069834A1 (no) |
| ZA (2) | ZA200109341B (no) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA58636C2 (uk) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| WO2001038323A1 (en) | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| AU2001255399A1 (en) * | 2000-04-14 | 2001-10-30 | Corvas International, Inc. | Pyridine and pyrazine derivatives as thrombin inhibitors |
| US6506754B1 (en) | 2000-04-14 | 2003-01-14 | Corvas International, Inc. | Non-covalent thrombin inhibitors |
| US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| US7243153B2 (en) | 2001-06-26 | 2007-07-10 | Eastman Kodak Company | System and method for managing images over a communication network |
| MXPA04003170A (es) * | 2001-10-03 | 2004-07-08 | Pharmacia Corp | Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion. |
| EP1482940A2 (en) * | 2001-10-03 | 2004-12-08 | Pharmacia Corporation | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| US20040106626A1 (en) * | 2001-10-03 | 2004-06-03 | Pharmacia Corporation | 6-Membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| EP1526131A1 (en) * | 2003-10-22 | 2005-04-27 | Graffinity Pharmaceuticals Aktiengesellschaft | Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors |
| US7905872B2 (en) * | 2004-06-04 | 2011-03-15 | The Procter & Gamble Company | Absorbent articles comprising a slow recovery stretch laminate |
| US9017305B2 (en) | 2010-11-12 | 2015-04-28 | The Procter Gamble Company | Elastomeric compositions that resist force loss and disintegration |
| US11584714B2 (en) | 2018-05-29 | 2023-02-21 | Omeros Corporation | MASP-2 inhibitors and methods of use |
| JP2022552048A (ja) | 2019-08-21 | 2022-12-15 | カルビスタ・ファーマシューティカルズ・リミテッド | 酵素阻害剤 |
| CN115052604A (zh) * | 2019-12-04 | 2022-09-13 | 奥默罗斯公司 | Masp-2抑制剂和使用方法 |
| CA3159167A1 (en) | 2019-12-04 | 2021-06-10 | Neil S. Cutshall | Masp-2 inhibitors and methods of use |
| JP2023504541A (ja) | 2019-12-04 | 2023-02-03 | オメロス コーポレーション | Ｍａｓｐ－２阻害剤および使用方法 |
| WO2021113682A1 (en) | 2019-12-04 | 2021-06-10 | Omeros Corporation | Masp-2 inhibitors and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2224437A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
| EP0900207B1 (en) * | 1996-04-23 | 2001-11-21 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| CA2283704A1 (en) * | 1997-03-24 | 1998-10-01 | Merck & Co., Inc. | Thrombin inhibitors |
| JP2001514227A (ja) * | 1997-09-05 | 2001-09-11 | メルク エンド カムパニー インコーポレーテッド | ピラジノン系トロンビン阻害薬 |
| WO1999059591A1 (en) * | 1998-05-19 | 1999-11-25 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| WO1999061442A1 (en) * | 1998-05-26 | 1999-12-02 | Merck & Co., Inc. | Imidazopyridine thrombin inhibitors |
| CN1769274A (zh) * | 1998-06-11 | 2006-05-10 | 奥瑟－麦内尔制药公司 | 吡嗪酮蛋白酶抑制剂 |
-
2000
- 2000-05-18 MX MXPA01011807A patent/MXPA01011807A/es unknown
- 2000-05-18 AU AU49723/00A patent/AU775229B2/en not_active Ceased
- 2000-05-18 EA EA200101212A patent/EA005031B1/ru not_active IP Right Cessation
- 2000-05-18 PL PL00352368A patent/PL352368A1/xx not_active Application Discontinuation
- 2000-05-18 DE DE60019296T patent/DE60019296T2/de not_active Expired - Fee Related
- 2000-05-18 IL IL14624500A patent/IL146245A0/xx unknown
- 2000-05-18 ES ES00931916T patent/ES2240100T3/es not_active Expired - Lifetime
- 2000-05-18 NZ NZ514876A patent/NZ514876A/en not_active Application Discontinuation
- 2000-05-18 BR BR0011295-0A patent/BR0011295A/pt not_active IP Right Cessation
- 2000-05-18 WO PCT/US2000/008225 patent/WO2000069834A1/en not_active Application Discontinuation
- 2000-05-18 EP EP00931916A patent/EP1202975B1/en not_active Expired - Lifetime
- 2000-05-18 CN CN00807726A patent/CN1351595A/zh active Pending
- 2000-05-18 JP JP2000618251A patent/JP2002544264A/ja active Pending
- 2000-05-18 HU HU0202191A patent/HUP0202191A3/hu unknown
- 2000-05-18 CA CA002372617A patent/CA2372617A1/en not_active Abandoned
- 2000-05-18 SK SK1587-2001A patent/SK15872001A3/sk unknown
- 2000-05-18 KR KR1020017014752A patent/KR20010113971A/ko not_active Application Discontinuation
- 2000-05-18 CZ CZ20014115A patent/CZ20014115A3/cs unknown
- 2000-05-18 AT AT00931916T patent/ATE292629T1/de not_active IP Right Cessation
- 2000-05-19 AR ARP000102447A patent/AR029752A1/es unknown
- 2000-05-19 UY UY26155A patent/UY26155A1/es not_active Application Discontinuation
- 2000-06-15 PE PE2000000593A patent/PE20010290A1/es not_active Application Discontinuation
-
2001
- 2001-11-13 ZA ZA200109341A patent/ZA200109341B/xx unknown
- 2001-11-16 NO NO20015605A patent/NO20015605L/no not_active Application Discontinuation
-
2004
- 2004-01-21 ZA ZA200400455A patent/ZA200400455B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60019296T2 (de) | 2006-03-09 |
| EA200101212A1 (ru) | 2002-06-27 |
| AU4972300A (en) | 2000-12-05 |
| BR0011295A (pt) | 2002-05-28 |
| SK15872001A3 (sk) | 2002-10-08 |
| AU775229B2 (en) | 2004-07-22 |
| WO2000069834A1 (en) | 2000-11-23 |
| AR029752A1 (es) | 2003-07-16 |
| NO20015605D0 (no) | 2001-11-16 |
| EP1202975B1 (en) | 2005-04-06 |
| PL352368A1 (en) | 2003-08-25 |
| UY26155A1 (es) | 2000-12-29 |
| IL146245A0 (en) | 2002-07-25 |
| ZA200400455B (en) | 2004-09-29 |
| MXPA01011807A (es) | 2003-09-04 |
| ZA200109341B (en) | 2004-05-26 |
| CA2372617A1 (en) | 2000-11-23 |
| HUP0202191A2 (hu) | 2002-12-28 |
| ES2240100T3 (es) | 2005-10-16 |
| CZ20014115A3 (cs) | 2002-05-15 |
| HUP0202191A3 (en) | 2003-02-28 |
| EA005031B1 (ru) | 2004-10-28 |
| CN1351595A (zh) | 2002-05-29 |
| ATE292629T1 (de) | 2005-04-15 |
| JP2002544264A (ja) | 2002-12-24 |
| DE60019296D1 (de) | 2005-05-12 |
| NZ514876A (en) | 2005-03-24 |
| KR20010113971A (ko) | 2001-12-28 |
| PE20010290A1 (es) | 2001-03-07 |
| EP1202975A1 (en) | 2002-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015605L (no) | Substituerte polysykliske aryl- og heteroarylpyrazinoner som er anvendbare for selektiv inhibering av koagulasjonskaskaden | |
| NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE350364T1 (de) | Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen | |
| NO20011940L (no) | Substituerte benzopyrananaloger for behandling av inflammasjon | |
| NO20012995L (no) | Forbindelser nyttige for behandling av inflammatoriske sykdommer | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| IL146244A0 (en) | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade | |
| AU2001243598A1 (en) | Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade | |
| NO995723D0 (no) | Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer | |
| NO995722L (no) | Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer | |
| FI990509A (fi) | Häiriönpoistomenetelmä | |
| NO20012541D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| AU2001219236A1 (en) | Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade | |
| NO983784L (no) | Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider | |
| NO20012612D0 (no) | Isonipecotamider for behandling av integren-formidlede lidelser | |
| NO20012540D0 (no) | Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner | |
| AU2001222501A1 (en) | Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade | |
| NO20012811D0 (no) | Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat | |
| AU2001217827A1 (en) | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade | |
| DK1202975T3 (da) | Substituerede polycycliske aryl- og heteroarylpyrazinoner, der er nyttige til selektiv inhibering af koagulationskaskaden | |
| NO983622D0 (no) | Fremgangsmåte for tildanning av lededör | |
| FI980469A0 (fi) | Arrangemang foer faestande av en begraensningsstaong vid en dragstaong | |
| NO996166D0 (no) | Fremgangsmåte for behandling av avluter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |